Surface Oncology, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (20)

Latest Posts

About This Stock More About This Stock
Stock Charts To Watch - Thursday, December 10
Video By: Harry Boxer
Thursday, December 10, 2020 10:17 PM EDT
Fulgent Genetics, Inc. popped out and pulled back on Thursday, but still finished up 3.07, or 6.39%, to 51.08, with a session high of 54.14, on 2.9 million shares traded. I think this stock will go higher. My target is 65.00 next.
In this video: PERI, NTLA, FLGT, SURF, JMIA
Watch
Stock Charts To Watch - Wednesday, May 20
Video By: Harry Boxer
Wednesday, May 20, 2020 9:00 PM EDT
Cloudera, Inc. broke out of a platform on Wednesday that has been forming for 7 or 8 weeks.
In this video: CLDR, CMCM, INO, KRNT, PENN, NGVT, SURF
Watch
Morning Call For Wednesday, Sept. 19
Article By: Jim Van Meerten
Wednesday, September 19, 2018 8:15 AM EDT
Dec E-mini S&Ps (ESZ18 -0.09%) this morning are down -0.04% and European stocks are down -0.05% in uninspired trade.
In this article: DO, HAL, JNPR, LYB, RIG, INAP, KAMN, RFP, PRQR, TRVG, BHGE, SURF, TLRY, EVOP
Read
Should You Buy Biotech IPOs?
Article By: Marc Lichtenfeld
Monday, September 17, 2018 7:52 PM EDT
Biotech is arguably the most exciting sector to invest in. This year, the NYSE Arca Biotechnology Index has more than doubled the S&P 500’s 14.6% total return with a 32.5% gain.
In this article: PTIE, LLY, ECYT, SLDB, SRRK, SURF, NTGN, VCNX, RGEN, NTLA
Read
How To Manage Risk In Speculative Biotech Stocks
Article By: Marc Lichtenfeld
Tuesday, April 24, 2018 5:19 AM EDT
Biotech IPOs are a special animal. Not only are the companies usually not profitable, but most of the time they don’t even have a product on the market yet.
In this article: ABBV, SURF
Read

Latest Tweets for $SURF

No tweets yet!

PARTNER HEADLINES